You can even look at such small fragments of the RNA (Ribonucleic acid) that you can check whether a patient is coming out of it or going into COVID.

Chris Toumazou

Christofer "Chris" Toumazou, FRS, FREng, FMedSci, FIET, FIEEE, FCGI, FRSM, CEng (Greek: ??????????? ????????, born 5 July 1961) is a British Cypriot electronic engineer. In 2013 he became London's first Regius Professor of Engineering conferred to Imperial College London during the Queen's Diamond Jubilee. Toumazou is also Chief Scientist of the Institute of Biomedical Engineering and Professor of Circuit Design at Imperial; Founder of Toumaz Holdings Ltd, Executive chairman and Founder of DNA Electronics Ltd., Chief Scientific Advisor to GENEU and a Co-Founder of DNAnudgeHe has been involved in developing new technologies, mainly in medical field, creating a research institute and a number of commercial ventures to commercialise his research. Toumazou invented and licensed Portable and Rapid Semiconductor Genome Sequencing which has now become a multimillion-dollar industry. One of his motivators was the diagnosis of his 13-year-old son with end stage kidney failure through a rare genetic mutation.He has published over 500 research papers and holds 50 patents in the field of semiconductors and healthcare. Toumazou's career began with the invention and development of novel concept of current-mode analogue circuitry for ultra-low-power electronic devices. For his inventions on semiconductor based genetic testing he won the Gabor Medal of the Royal Society (2013) and European Inventor Award (2014). He is the first British winner of the prize in this contest since 2008.

All Chris Toumazou quotes | Chris Toumazou Books